Author:
Stein D S,Creticos C M,Jackson G G,Bernstein J M,Hayden F G,Schiff G M,Bernstein D I
Abstract
A loading dose and short-term administration of oral ribavirin significantly improved symptoms and signs of influenza type A or B infection in 25 patients. The antiviral effect was not significant. No adverse clinical effects or significant laboratory values were observed. Oral treatment of patients with influenza A or B infection might be possible with ribavirin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference13 articles.
1. Occurrence of amantadine and rimantadine resistant influenza A virus strains during the 1980 epidemic;Heider H.;Acta Virol.,1981
2. Sensitivity of influenza A virus to amantadine;Jackson G. G.;J. Infect. Dis.,1977
3. Jackson G. G. R. L. Muldoon and L. W. Akers. 1964. Serological evidence for prevention of influenzal infection in volunteers by an anti-influenzal drug adamantanamine hydrochloride p. 703-707. Antimicrob. Agents Chemother. 1963.
4. Knight V. S. Z. Wilson J. M. Quarles S. E. Greggs H. W. McClung B. K. Waters R. W. Cameron J. M. Zerwas and R. B. Couch. 1981. Ribavirin small particle aerosol treatment of influenza. Lancet i:945-949.
5. Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers;Magnussen C. R.;Antimicrob. Agents Chemother.,1977
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献